留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

Trio-WES在NT增厚胎儿产前诊断中的临床应用价值

周培,  余梅,  吴仁花,  袁静

周培, 余梅, 吴仁花, 袁静. Trio-WES在NT增厚胎儿产前诊断中的临床应用价值[J]. 中华全科医学, 2026, 24(5): 821-824. doi: 10.16766/j.cnki.issn.1674-4152.004499
引用本文: 周培, 余梅, 吴仁花, 袁静. Trio-WES在NT增厚胎儿产前诊断中的临床应用价值[J]. 中华全科医学, 2026, 24(5): 821-824. doi: 10.16766/j.cnki.issn.1674-4152.004499
ZHOU Pei, YU Mei, WU Renhua, YUAN Jing. Clinical application value of Trio-WES in prenatal diagnosis of fetuses with increased nuchal translucency[J]. Chinese Journal of General Practice, 2026, 24(5): 821-824. doi: 10.16766/j.cnki.issn.1674-4152.004499
Citation: ZHOU Pei, YU Mei, WU Renhua, YUAN Jing. Clinical application value of Trio-WES in prenatal diagnosis of fetuses with increased nuchal translucency[J]. Chinese Journal of General Practice, 2026, 24(5): 821-824. doi: 10.16766/j.cnki.issn.1674-4152.004499

Trio-WES在NT增厚胎儿产前诊断中的临床应用价值

doi: 10.16766/j.cnki.issn.1674-4152.004499
基金项目: 

国家重点研发计划项目 2021YFC1005303

详细信息
    通讯作者:

    袁静,E-mail: yuanjing_@163.com

  • 中图分类号: R714.55

Clinical application value of Trio-WES in prenatal diagnosis of fetuses with increased nuchal translucency

  • 摘要:   目的  评估家系全外显子组测序(Trio-WES)对NT增厚胎儿产前遗传学诊断的临床效能及应用意义。  方法  选取2023年8月-2025年3月于安徽医科大学第一附属医院就诊的50例NT增厚单胎妊娠孕妇, 所有病例均同步接受羊水染色体核型、染色体微阵列分析(CMA)及Trio-WES检测, 对上述检测结果进行回顾性比较与分析。  结果  在50例NT增厚胎儿中, 遗传学检测结果显示34例(68.0%)正常, 16例(32.0%)存在异常。其中, 染色体核型检出异常5例(10.0%); CMA检出异常10例(20.0%); Trio-WES共检出异常16例(32.0%), 包括5例染色体数目异常(与染色体核型及CMA一致)、4例拷贝数变异(与CMA一致)以及7例单基因致病性变异(额外检出率为14.0%)。染色体核型与CMA的阳性率差异无统计学意义(P=0.074);Trio-WES的阳性率显著高于染色体核型(P < 0.001);而CMA与Trio-WES的阳性率差异无统计学意义(P>0.017)。在NT增厚合并高龄妊娠(孕妇年龄≥35岁)的病例中, Trio-WES异常检出率显著升高(P=0.014)。  结论  Trio-WES可显著提升NT增厚胎儿的遗传学诊断效能, 对单基因病具有独特诊断价值, 尤其在高龄妊娠群体中应用意义显著。

     

  • 表  1  16例NT增厚胎儿遗传学检测异常结果汇总

    Table  1.   Summary of genetic abnormalities in 16 fetuses with thickened NT

    序号 年龄
    (岁)
    NT值
    (mm)
    核型结果 CMA结果 CMA致
    病性评级
    Trio-WES结果 WES致
    病性评级
    1 36 3.6 47, XN, +18 arr(18)×3 致病 seq(18)×3 致病
    2 36 3.7 47, XN, +21 arr(21)×3 致病 seq(21)×3 致病
    3 28 3.9~4.2 47, XN, +21 arr(21)×3 致病 seq(21)×3 致病
    4 27 4.2 47, XN, +21 arr(21)×3 致病 seq(21)×3 致病
    5 35 2.8 47, XN, +21 arr(21)×3 致病 seq(21)×3 致病
    6 23 2.8~3.1 46, XN arr[GRCh37]22q11.22q11.23
    (22, 997, 929_23, 650, 874)x1
    意义不明 seq[GRCh37]del(22)(q11.22q11.23)
    chr22:g.22989227_23657714del
    意义不明
    7 31 4.3 46, XN arr[GRCh37]17q22
    (55501204_56476808)x1
    可能致病 seq[GRCh37]del(17)(q22q22)
    chr17:g.55509901_56448393del
    可能致病
    8 35 5.0 46, XN arr[GRCh37]9p24.3p22.2
    (208, 455_17, 792, 136)x1
    致病 seq[GRCh37]del(9)(p24.3p22.2)
    chr9:g.134943_17789557del
    致病
    9 32 4.3 46, XN arr[GRCh37]18p11.32p11.21
    (136, 228_15, 099, 116)x1
    致病 seq[GRCh37]del (18)(p11.32p11.21)
    chr18:g.47340_14853917del
    致病
    10 30 2.8~3.2 46, XN arr[GRCh37](1-22)x2, (XN)x1 / PTEN基因c.492+2T>C杂合变异 可能致病
    11 32 2.6 46, XN arr[GRCh37](1-22)x2, (XN)x1 / LDLR基因exon1-2del杂合变异 可能致病
    12 24 4.3~4.5 46, XN arr[GRCh37](1-22)x2, (XN)x1 / DPYS基因c.1393C>T
    DPYS基因c.48C>G复合杂合变异
    致病
    可能致病
    13 36 4.1 46, XN arr[GRCh37]12p11.23p11.22
    (26, 661, 888_28, 097, 149)x1
    意义不明 ARID2基因c.2516del杂合变异 可能致病
    14 36 2.9 46, XN arr[GRCh37](1-22)x2, (XN)x1 / LZTR1基因c.742G>A杂合变异 可能致病
    15 37 4.8 46, XN arr[GRCh37](1-22)x2, (XN)x1 / LDLR基因c.1747C>T杂合变异 致病
    16 35 9.3 46, XN arr[GRCh37](1-22)x2, (XN)x1 / SHOC2基因c.4A>G杂合变异 致病
    注:“ /”代表检测结果正常无致病性评级。
    下载: 导出CSV

    表  2  Trio-WES额外检出的7例单基因变异信息

    Table  2.   Information on an additional 7 cases of single-gene variants detected by Trio-WES

    序号 NT值(mm) 基因变异位点 致病性评级 变异来源 相关疾病
    1 2.8~3.2 PTEN基因c.492+2T>C杂合变异 可能致病(PVS1+PM2_P) 父源 Cowden综合征1型
    2 2.6 LDLR基因exon1-2del杂合变异 可能致病(PVS1+PM2_P) 母源 家族性高胆固醇血症1型
    3 4.3~4.5 DPYS基因c.1393C>T杂合变异
    DPYS基因c.48C>G杂合变异
    致病(PVS1+PS3+PM2_P+PM3_P)
    可能致病(PS3+PM2_P+PM3)
    父源
    母源
    二氢尿嘧啶酶缺陷症
    4 4.1 ARID2基因c.2516del杂合变异 可能致病(PVS1+PM2_P) 母源 Cofn-Siris综合征6型
    5 2.9 LZTR1基因c.742G>A杂合变异 可能致病
    (PS2+PS3_P+PS4_M+PM2_P+PP3)
    新生
    变异
    Noonan综合征2型
    6 4.8 LDLR基因c.1747C>T杂合变异 致病(PS4+PP1_S+PP3) 父源 家族性高胆固醇血症1型
    7 9.3 SHOC2基因c.4A>G杂合变异 致病(PS2_VS+PS4+PM2_P) 新生
    变异
    Noonan综合征样病伴生长期
    毛发松动症1型
    下载: 导出CSV

    表  3  3种检测方法阳性率比较[例(%)]

    Table  3.   Comparison of positive rates of the three detection methods[cases(%)]

    检测方法 阳性 阴性
    染色体核型 5(10.0) 45(90.0)
    CMA 10(20.0) 40(80.0)
    Trio-WES 16(32.0)a 34(68.0)
    χ2值 9.091
    P值 < 0.001
    注:与染色体核型比较,aP < 0.017。
    下载: 导出CSV
  • [1] 付华钰, 苏家荪, 黄婧, 等. 胎儿颈项透明层在2.5~2.9 mm时进行产前诊断的必要性研究[J]. 中华全科医学, 2025, 23(6): 972-976. doi: 10.16766/j.cnki.issn.1674-4152.004045

    FU H Y, SU J S, HUANG J, et al. Study on the necessity of prenatal diagnosis when fetal nuchal translucency is between 2.5 and 2.9 mm[J]. Chinese Journal of General Practice, 2025, 23(6): 972-976. doi: 10.16766/j.cnki.issn.1674-4152.004045
    [2] 佟玉龙, 李昶, 于丽, 等. 胎儿颈项透明层增厚在产前诊断中的临床意义和预后分析[J]. 中国生育健康杂志, 2023, 34(5): 476-478, 497.

    TONG Y L, LI C, YU L, et al. Clinical significance and prognosis analysis of increased fetal nuchal translucency in prenatal diagnosis[J]. Chinese Journal of Reproductive Health, 2023, 34(5): 476-478, 497.
    [3] 闫冰, 陈萍, 曹云云, 等. 单脐动脉及合并畸形的产前超声分析[J]. 诊断学理论与实践, 2023, 22(1): 31-36.

    YAN B, CHEN P, CAO Y Y, et al. Prenatal ultrasound analysis of single umbilical artery and combined malformations[J]. Journal of Diagnostics Concepts & Practice, 2023, 22(1): 31-36.
    [4] 李荣, 林晓莹, 吴晓昀, 等. 超声结合WES对Treacher Collins综合征胎儿的产前诊断[J]. 中国产前诊断杂志(电子版), 2022, 14(1): 45-49.

    LI R, LIN X Y, WU X Y, et al. Prenatal diagnosis of a fetal with Treacher Collins syndrome by ultrasound and WES[J]. Chinese Journal of Prenatal Diagnosis(Electronic Version), 2022, 14(1): 45-49.
    [5] 廖灿. 染色体微阵列技术及全外显子测序在先心病产前诊断中的应用价值[J]. 中国产前诊断杂志(电子版), 2023, 15(1): 6-12.

    LIAO C. The application value of chromosomal microarray analysis and whole exome sequencing in prenatal diagnosis of congenital heart disease[J]. Chinese Journal of Prenatal Diagnosis(Electronic Version), 2023, 15(1): 6-12.
    [6] 李萌, 蒙达华, 付华钰, 等. 199例妊娠中晚期胎儿室间隔缺损的遗传学因素研究[J]. 中华全科医学, 2023, 21(2): 267-269. doi: 10.16766/j.cnki.issn.1674-4152.002861

    LI M, MENG D H, FU H Y, et al. Genetic factors of ventricular septal defect in 199 cases in the second or third trimester of pregnancy[J]. Chinese Journal of General Practice, 2023, 21(2): 267-269. doi: 10.16766/j.cnki.issn.1674-4152.002861
    [7] JI X Q, LI Q M, QI Y M, et al. When NIPT meets WES, prenatal diagnosticians face the dilemma: genetic etiological analysis of 2, 328 cases of NT thickening and follow-up of pregnancy outcomes[J]. Front Genet, 2023, 14: 1227724. DOI: 10.3389/fgene.2023.1227724.
    [8] VO T M, HOANG N T, NGUYEN T T, et al. Chromosomal anomalies in fetuses with increased nuchal translucency: a Vietnamese retrospective study[J]. Cureus, 2024, 16(10): e72235. DOI: 10.7759/cureus.72235.
    [9] 邱惠国, 张彧梅. 染色体微阵列联合染色体核型分析对颈项透明层增厚胎儿的产前诊断价值[J]. 中国妇幼保健, 2024, 39(24): 4959-4963.

    QIU H G, ZHANG Y M. The value of chromosomal microarray analysis combined with karyotyping in prenatal diagnosis of fetuses with increased nuchal translucency[J]. Maternal and Child Health Care of China, 2024, 39(24): 4959-4963.
    [10] 侯磊, 李介岩, 齐科研, 等. 5例努南综合征胎儿的产前诊断家系分析[J]. 生殖医学杂志, 2024, 33(8): 1074-1079.

    HOU L, LI J Y, QI K Y, et al. Prenatal diagnosis and genetic analysis of 5 fetuse of Noonan syndrome[J]. Journal of Reproductive Medicine, 2024, 33(8): 1074-1079.
    [11] 代海兵, 鄢盛恺. 家族性高胆固醇血症的基因诊断研究进展[J]. 临床心血管病杂志, 2023, 39(5): 348-354.

    DAI H B, YAN S K. Research progress in genetic diagnosis of familial hypercholesterolemia[J]. Journal of Clinical Cardiology, 2023, 39(5): 348-354.
    [12] SCHRIER VERGANO S A. ARID2, a milder cause of Coffin-Siris syndrome? Broadening the phenotype with 17 additional individuals[J]. American J Med Genetics Pt A, 2024, 194(6): e63540. DOI: 10.1002/ajmg.a.63540.
    [13] KASERA B, SHINAR S, EDKE P, et al. Deep-learning computer vision can identify increased nuchal translucency in the first trimester of pregnancy[J]. Prenat Diagn, 2024, 44(5): 535-543. doi: 10.1002/pd.6559
    [14] LI C Y, WANG Y, ZENG C Z, et al. Trio-whole exome sequencing reveals the importance of de novo variants in children with intellectual disability and developmental delay[J]. Sci Rep, 2024, 14(1): 27590. DOI: 10.1038/s41598-024-79431-x.
    [15] ZHOU Y L, LU X X, ZHANG Y H, et al. Prenatal genetic diagnosis of fetal cystic hygroma: a retrospective single-center study from China[J]. Cytogenet Genome Res, 2022, 162(7): 354-364. doi: 10.1159/000528600
    [16] HUANG R B, FU F, ZHOU H, et al. Prenatal diagnosis in the fetal hyperechogenic kidneys: assessment using chromosomal microarray analysis and exome sequencing[J]. Hum Genet, 2023, 142(6): 835-847. doi: 10.1007/s00439-023-02545-1
    [17] 刘建珍, 林铿, 覃燕龄, 等. 染色体微阵列技术贯序全外显子组测序在胎儿超声异常产前诊断的应用价值[J]. 中国产前诊断杂志(电子版), 2025, 17(2): 25-32.

    LIU J Z, LIN K, QIN Y L, et al. The application value of chromosomal microarray technology and sequential whole exome sequencing in prenatal diagnosis of fetal ultrasound abnormalities[J]. Chinese Journal of Prenatal Diagnosis(Electronic Version), 2025, 17(2): 25-32.
    [18] 王芳, 张秀珍, 吕建利. 高龄孕妇胎儿颈项透明层及染色体核型检测的临床意义[J]. 新乡医学院学报, 2023, 40(8): 759-764.

    WANG F, ZHANG X Z, LYU J L. Clinical significance of fetal nuchal translucency and chromosome karyotype testing in advanced maternal age pregnant women[J]. Journal of Xinxiang Medical University, 2023, 40(8): 759-764.
    [19] ZENG Z Y, ZHANG L, ZHOU Y Q, et al. Clinical utility of trio whole exome sequencing in fetuses with ultrasound anomalies[J]. Hum Genomics, 2025, 19(1): 37. DOI: 10.1186/s40246-025-00745-6.
    [20] GUSEVA M, SHIROKOVA N, KAPITONOVA O, et al. Application of whole-exome sequencing (WES) for prenatal determination of causes of fetal abnormalities[J]. Genes, 2025, 16(5): 547. DOI: 10.3390/genes16050547.
    [21] QIAN G H, YANG N Y, DENG F, et al. SNV/indel and CNV analysis in trio-WES for intellectual and developmental disabilities: diagnostic yield & cost-effectiveness[J]. Clin Genet, 2025, 107(4): 402-412. doi: 10.1111/cge.14677
表(3)
计量
  • 文章访问数:  7
  • HTML全文浏览量:  3
  • PDF下载量:  1
  • 被引次数: 0
出版历程
  • 收稿日期:  2025-10-23
  • 网络出版日期:  2026-10-23

目录

    /

    返回文章
    返回